Holen Sie sich die Stockscreener-App
8.18
5.14%
0.40
Finanzdaten der Aspire Biopharma Holdings Inc-Aktie (ASBP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
122.57%
0.0631
|
0.0284 | 0.00426 | 0.00194 | - |
| Cost Of Revenue |
124.83%
0.0508
|
0.0226 | 0.00526 | 0.00106 | - |
| Gross Profit |
623.23%
-0.0301
|
0.00575 | -0.001 | 0.000884 | - |
| Operating Expenses |
60.31%
2.6481
|
1.6519 | 1.8484 | 1.1464 | 0.7999 |
| Operating Income/Loss |
62.69%
-2.6782
|
-1.6462 | -1.8494 | -1.1455 | - |
| Nonoperating Income/Loss |
189.43%
1.4101
|
-1.5767 | -2.8583 | -0.705 | -1.1814 |
| Income/Loss From Continuing Operations Before Tax |
60.65%
-1.2681
|
-3.2229 | - | -1.8505 | -1.9813 |
| Net Income/Loss |
60.65%
-1.2681
|
-3.2229 | -4.7077 | -1.8505 | -1.9813 |
| Basic Average Shares |
562.40%
1.0379
|
0.1567 | - | 49.53 | - |
| Diluted Average Shares |
562.40%
1.0379
|
0.1567 | - | 49.53 | - |
| Basic Earnings Per Share |
94.07%
-1.22
|
-20.57 | - | -0.04 | - |
| Diluted Earnings Per Share |
94.07%
-1.22
|
-20.57 | - | -0.04 | - |
0.79%
4.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):